FINWIRES · TerminalLIVE
FINWIRES

$SBRA

5 stories mentioning SBRAUpdated 1d ago

Every FINWIRES story that references SBRA, newest first.

Research

Raymond James Upgrades Sabra Health Care REIT to Market Perform From Underperform

Sabra Health Care REIT (SBRA) has an average rating of overweight and mean price target of $22.71, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

$SBRA
Wire

Sabra Health Care REIT Re-Tenants 26 Properties; Raises 2026 AFFO Guidance

Sabra Health Care REIT (SBRA) said Tuesday it has signed letters of intent to re-tenant all of its 26 properties leased to healthcare company Avamere.Under the deal, 22 properties will be transitioned to subsidiaries of healthcare operator Cascadia Healthcare, while the other four would be transitioned to subsidiaries of an existing Sabra tenant, the company said.The combined annualized cash rent of the portfolio is expected to be $53 million, a nearly 30% increase from the $41 million received from Avamere during the trailing 12-month period ending March 31, the company said.The transition is expected to be completed during the second half of the year.The company also raised its 2026 guidance for adjusted funds from operations to a range of $1.59 to $1.61 per diluted share, from previous guidance of $1.55 to $1.59.Sabra Health Care REIT shares were 5.5% higher in Tuesday trading.Price: $20.91, Change: $+0.91, Percent Change: +4.55%

$SBRA
Research

Truist Upgrades Sabra Health Care REIT to Buy From Hold, Keeps $22 Price Target

Sabra Health Care REIT (SBRA) has an average rating of overweight and mean price target of $22, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

$SBRA
Research

Citigroup Downgrades Sabra Health Care REIT to Neutral From Buy, Cuts Price Target to $19 From $24

Sabra Health Care REIT (SBRA) has an average rating of overweight and mean price target of $22.15, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

$SBRA
Wire

UBS Adjusts Price Target on Sabra Health Care REIT to $22 From $21, Maintains Neutral Rating

Sabra Health Care REIT (SBRA) has an average rating of overweight and mean price target of $22.31, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $20.96, Change: $-0.02, Percent Change: -0.07%

$SBRA

Track with the FINWIRES app suite